Spruce Biosciences Inc (SPRB)
0.747
-0.02
(-2.97%)
USD |
NASDAQ |
May 17, 16:00
0.747
0.00 (0.00%)
After-Hours: 20:00
Spruce Biosciences Debt to Equity Ratio: 0.0442 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0442 |
| December 31, 2023 | 0.0436 |
| September 30, 2023 | 0.0437 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0428 |
| March 31, 2023 | 0.0419 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0419
Minimum
Mar 2023
0.0442
Maximum
Mar 2024
0.0432
Average
0.0436
Median
Dec 2023
Debt to Equity Ratio Benchmarks
| Vanda Pharmaceuticals Inc | 0.00 |
| ADMA Biologics Inc | 0.8513 |
| Coherus BioSciences Inc | -5.800 |
| TRACON Pharmaceuticals Inc | 0.00 |
| Entero Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 87.54M |
| Total Liabilities (Quarterly) | 20.92M |
| Shareholders Equity (Quarterly) | 66.62M |
| Current Ratio | 4.668 |
| Net Debt Paydown Yield | 0.61% |